title: Demodicidosis associated with psoriasis therapy--two case reports.
authors.forename: Michael
authors.initials: M
authors.lastname: Zirbs
authors.forename: Vagkan
authors.initials: V
authors.lastname: Mourantchanian
authors.forename: Elena
authors.initials: E
authors.lastname: Radopoulou
authors.forename: Jan
authors.initials: J
authors.lastname: Gutermuth
authors.forename: Christian
authors.initials: C
authors.lastname: Andres
authors.forename: Johannes
authors.initials: J
authors.lastname: Ring
authors.forename: Knut
authors.initials: K
authors.lastname: Brockow
mesh_terms: D017255:Acitretin / Q000627:therapeutic use; D000368:Aged; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D007641:Keratolytic Agents / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D008924:Mite Infestations / Q000139:chemically induced* / Q000188:drug therapy / Q000473:pathology; D008925:Mites; D011701:PUVA Therapy; D011565:Psoriasis / Q000188:drug therapy*; D013256:Steroids / Q000009:adverse effects / Q000627:therapeutic use; D016559:Tacrolimus / Q000009:adverse effects / Q000031:analogs & derivatives / Q000627:therapeutic use
chemical_list: D000893:Anti-Inflammatory Agents; D007166:Immunosuppressive Agents; D007641:Keratolytic Agents; D013256:Steroids; C117268:pimecrolimus; D017255:Acitretin; D016559:Tacrolimus